ROCKET PHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 108.32 million shares for the year ending 2025.

  • ROCKET PHARMACEUTICALS, INC. showed an increase of +1.8% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ROCKET PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2014 to 2025), ROCKET PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 10,518.7%.
  • Historical annual values: Fiscal year 2025: 108.32 million shares | Fiscal year 2024: 106.45 million shares | Fiscal year 2023: 90.28 million shares | Fiscal year 2022: 79.12 million shares | Fiscal year 2021: 64.51 million shares | Fiscal year 2020: 61.00 million shares | Fiscal year 2019: 54.77 million shares | Fiscal year 2018: 45.14 million shares | Fiscal year 2017: 6.80 million shares | Fiscal year 2016: 6.75 million shares | Fiscal year 2015: 26.42 million shares | Fiscal year 2014: 1.02 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: